Pendapatan dodolan perusahaan aligos.com (ALGS)

Aligos Therapeutics (ALGS) aims to develop innovative molecules to combat NASH and hepatitis B. The company's trading revenue dynamics on the GURU.Markets daily price chart reflect progress toward this goal, where 0.03 represents the latest metric reading. Growth paths are hindered by the need to maintain high medical authority and the ongoing implementation of software automation for clinical data processing.

Aligos Therapeutics (ALGS): Pendapatan perusahaan saka 04.07.2022 nganti 14.11.2026

Rincian metrik komprehensif lan analitis Aligos Therapeutics Inc. (ALGS)

- rega pasar lan target rega analis:

Rega bursa Aligos|ALGS - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Aligos Therapeutics, Inc.|ALGS - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Aligos Therapeutics|ALGS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku aligos.com|ALGS - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Koefisien Total Utang marang Modal Aligos Therapeutics|ALGS - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Aligos|ALGS - Utang perusahaan|Utang-utang marang nilai buku Aligos Therapeutics, Inc.|ALGS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Aligos Therapeutics|Rasio jangkoan perantara aligos.com

- data bathi resik lan rasio valuasi:

ALGS - Penghasilan resik|Bathi resik mangsa ngarep Aligos Therapeutics|ALGS - Pangali P/E|Pangali mangsa ngarep rega marang bathi Aligos|ALGS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aligos Therapeutics, Inc.|ALGS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Aligos Therapeutics|ALGS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan aligos.com|ALGS - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Aligos Therapeutics

- indikator volume dodolan lan pendapatan:

ALGS - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Aligos|ALGS - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Aligos Therapeutics, Inc.

Analisis komprehensif perusahaan:ALGS (aligos.com)

For Aligos Therapeutics (ALGS), which is developing innovative treatments for hepatitis B, monitoring cash inflows serves as an indicator of the commercialization of its scientific research. This metric aggregates the daily volume of funds from product sales, reflecting the actual market demand for the drugs. The revenue dynamics from the company's commercial activities allow for a comparison of actual growth rates against management's internal plans. A declining curve warns of sales stagnation, while sharp peaks indicate a risk of asset overvaluation.

Analisis perusahaan pesaing

Total pendapatan perusahaan Arrowhead Corp ARWR|Pendapatan perusahaan Mirum Pharmaceuticals (MIRM)|DVAX (Dynavax Technologies Corporation) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ABUS (Arbutus Biopharma Corporation)|Pendapatan lan volume dodolan Inventiva SA IVA|GYRE - Pendapatan perusahaan|ASMB: Pendapatan perusahaan|GALT: Pendapatan lan volume dodolan|GNFT - Pendapatan reged perusahaan|DRRX (DURECT Corp) - Pendapatan lan volume dodolan|BIVI - Total volume dodolan perusahaan|Pendapatan perusahaan Galmed Pharmaceuticals (GLMD)|NDRA - Total pendapatan perusahaan|Pendapatan perusahaan Hepion Pharmaceuticals, Inc. HEPA